Right here, we explain a pharmacogenetics tactic that permits to selectively and reversibly inactivate LC neurons using Designer Receptors Completely Activated by Designer Medicine (DREADD). We present that the expression from the hM4Di DREADD is usually restricted to noradrenergic LC neurons Which the level of LC inhibition is usually altered by a